Vincent Shier > Haynes and Boone, L.L.P. > Washington DC, United States > Lawyer Profile
Haynes and Boone, L.L.P. Offices
800 17TH STREET, NW
WASHINGTON DC
United States
- Firm Profile
- Go to...
Vincent Shier
Work Department
Healthcare/Life Sciences, Intellectual Property, Precision Medicine and Digital Health
Position
Partner
Career
Vincent K. Shier, Ph.D. is a partner in the Intellectual Property Practice Group in Haynes Boone’s Washington, D.C. office.
Drawing from his cross-discipline education, Vince’s practice focuses on representing clients in the biotechnology, life sciences, and pharmaceutical fields, as well as many chemical disciplines. These technologies include genetics, molecular biology, therapeutic methods, pharmaceuticals, DNA microarray technology, diagnostics, plants, food products, renewable energies, batteries, plastics, surface materials, minerals and mineral applications, along with an array of other chemical products and processes.
Vince holds a doctorate degree in biological chemistry and has practiced IP law for more than two decades, preparing and prosecuting patent applications, counseling clients in strategic IP considerations, and representing clients in post-grant proceedings at the U.S. Patent and Trademark Office (USPTO).
Vince has also been an adjunct professor of law at the Antonin Scalia Law School at George Mason University since 2019 teaching introductory patent law courses as well as course on patent and know-how licensing.
Top Tier Firm Rankings
Firm Rankings
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Insurance > Advice to policyholders
- Energy > Energy litigation: oil and gas
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Finance > Structured finance: derivatives and structured products
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Energy > Energy litigation: electric power
- Healthcare > Life sciences
- Finance > Financial services regulation